自2022年3月诺华公司推出 ...

专注于高价值女性健康诊断的Sera Prognostics，市值1.34亿美元，其股价触及52周新低，报收$3.84。根据 InvestingPro 数据显示，该股RSI指标显示超卖区域，表明当前价位可能存在技术支撑。这一价格水平较此前位置显著下跌，标志着公司市值正经历艰难时期。过去一年，Sera ...

盐湖城讯— Sera Prognostics , Inc. (NASDAQ: SERA )的首席科学官Boniface John J.近期出售了5,915股公司A类普通股。这些股票以加权平均价$4.58出售，总计获得$27,090。此次交易是在$4.14至$5.09价格区间内完成的大宗交易的一部分。此次出售发生之际，SERA股价接近其52周低点$3.84，今年迄今股价下跌超过47%。

Harrison Robert Gardner, the Chief Information Officer of Sera Prognostics , Inc. (NASDAQ:SERA), recently sold 554 shares of ...

Sera Prognostics, a company specializing in high-value women's health diagnostics with a market capitalization of $134 million, has seen its stock price touch a 52-week low, trading at $3.84.

Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today ...

2025年2月14日， Sera Prognostics（SERA）披露8笔公司内部人交易情况。董事Lindgardt Zhenya于2025年2月13日卖出1.41万股。 Sera Prognostics, Inc.于2008年1月17日根据特拉华州法律注册成立。该公司是一家女性健康诊断公司，利用公司专有的蛋白质组学和生物信息学平台来发现、开发和商业化具有临床意义和经济影响的生物标志物测试 ...

Sera Prognostics (SERA) announced the pricing of its underwritten public offering of 1.25M shares of its Class A common stock at a public ...

Sera Prognostics (SERA) announced that it has commenced a proposed underwritten public offering of its Class A common stock and, in lieu of ...

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

About Sera Prognostics, Inc. Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to ...